Edwards Wildman adds former FTC official as IP partner in DC

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Edwards Wildman adds former FTC official as IP partner in DC

Edward Glynn has joined Edwards Wildman Palmer’s office in Washington, DC as a partner in its intellectual property department.

Glynn will advise clients involved in federal and state regulatory investigations.

Before joining Edwards Wildman, Glynn was a partner in the Washington, DC offices of Manatt, Phelps & Phillips and Venable. He previously spent 14 years as a senior official in the Federal Trade Commission (FTC), where he led the Commission’s regulatory oversight of cross-border mergers and acquisitions for almost a decade.

 

While at the FTC, Glynn represented the US on the Committee on Competition Law and Policy of the Organisation for Economic Co-operation and Development and was chair of the Committee’s Working Group on Competition Policy and Intellectual Property.

 

Glynn serves as vice-chair of the Consumer Protection Committee of the Antitrust Section, American Bar Association.

Edwards Wildman Palmer also announced that Bryan Zerhusen has joined the firm as a partner in its intellectual property department in Hartford, Connecticut.

Zerhusen counsels clients in all areas of molecular biology, biochemistry, and biotechnology. He was previously a Hartford-based partner in McCarter & English’s intellectual property and information technology group, where he helped to establish and grow the life sciences practice.

 

more from across site and ros bottom lb

More from across our site

Niall Trainor, managing attorney at Hasbro, says brands could boost their business with careful portfolio culling
A decision by the Paris Central Division will lead to more IP work for outside counsel, say sources
Courts are encouraged to deliver judgments within three months of a trial, but that deadline has been missed in several recent cases
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Michael DeVincenzo explains how he and his team convinced the Federal Circuit to find in favour of his client in a patent case against Salesforce
Funders and a litigator explain how litigation funding disclosure requirements could affect their business
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Discussions about whether to seek director reviews can come up frequently with clients, even though actual grant rates are rare
In the latest episode, we discuss why IP firms might be attractive to PE investors and bring you the latest news on submissions for next year’s IP STARS rankings
Back-to-back PE deals for IP firms in recent years show that IP firms are sitting on goldmines, so traditional partnerships should be open to change
Gift this article